Yu Zeng, Aixin Li, Jing Zhou, Hao Wen, Keqin Zhang, Qi Wu, Su Wen. "Cost-effectiveness of finotonlimab plus chemotherapy versus chemotherapy alone for recurrent or metastatic head and neck cancer in China." Scientific Reports, 2025. doi:10.1038/s41598-025-23864-5